Indian stock markets opened on a high note Monday, with the Sensex soaring 1,793.73 points to 81,248.20 and the Nifty climbing 553.25 points to 24,561.25, marking a powerful rebound following the India-Pakistan ceasefire agreement.
This was the first trading session since hostilities paused, and investors responded with confidence, pushing indices sharply higher across the board.
Experts say the rally reflects a renewed sense of stability at the border. Market analyst Ajay Bagga told ANI, “All losses caused by the India-Pakistan kinetic conflict have been recovered as hostilities subside. Indian markets have weathered the turbulence remarkably and are rebounding smartly.”
The recovery was also driven by robust inflows and positive global cues, including encouraging signs from US-China trade talks held in Geneva over the weekend.
-
Nifty Realty led sectoral gains with a rise of over 4%
-
Nifty Auto jumped 2.25%
-
Nifty IT rose 2.16%
Despite the broad rally, pharma stocks lagged, slipping by 1.3%. This decline came after US President Donald Trump announced plans to cap drug prices based on international benchmarks, potentially hitting revenues of Indian drug exporters.
Eight of the 20 pharmaceutical stocks on the sub-index were in the red, contrasting with the Nifty 50, which was trading 2.4% higher during the session.
-
Gold prices dropped over 2%, signaling a shift toward risk-on sentiment
-
Oil prices and the US dollar strengthened
-
US futures pointed to a 1% gain, boosting investor morale globally
With tensions easing on the geopolitical front and optimism building globally, Indian equities appear set for a period of resilient recovery and investor confidence.
